Biolab and Sandoz Partner to Launch Semaglutide Pen for Type 2 Diabetes in Brazil
Biolab and Sandoz collaborate to introduce Owozy, a semaglutide pen approved by Anvisa, targeting Brazil's high type 2 diabetes population with weekly injectable treatment.